Applied DNA Sciences informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Applied DNA Sciences utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BNBX | Applied DNA Sciences | -$240.00 | -$22.50 | — | — | $813.11K | $1.63M | — | — | 12/16/2025 | |
BNBX | Applied DNA Sciences | $352.50 | -$37.50 | -$33.41 | 10.91% | $797.52K | $1.28M | $304.39K | -76.14% | 08/14/2025 | |
BNBX | Applied DNA Sciences | -$2.03K | -$45.00 | -$230.25 | -411.67% | $929.63K | — | $983.37K | — | 05/15/2025 | |
BNBX | Applied DNA Sciences | -$67.50 | -$247.50 | -$420.00 | -69.70% | $891.16K | $1.18M | $1.20M | 1.44% | 02/13/2025 | |
BNBX | Applied DNA Sciences | -$195.00 | -$262.50 | -$240.00 | 8.57% | $779.74K | $899.00K | $813.11K | -9.55% | 12/17/2024 | |
BNBX | Applied DNA Sciences | -$1.80 | — | $352.50 | — | $2.92M | — | $797.52K | — | 08/08/2024 | |
BNBX | Applied DNA Sciences | -$150.00 | -$3.38K | -$2.03K | 39.78% | $4.41M | $950.00K | $929.63K | -2.14% | 05/10/2024 | |
BNBX | Applied DNA Sciences | -$225.00 | -$232.50 | -$67.50 | 70.97% | $5.26M | $780.00K | $891.16K | 14.25% | 02/08/2024 | |
BNBX | Applied DNA Sciences | $7.50 | -$202.50 | -$195.00 | 3.70% | $3.56M | $1.60M | $779.74K | -51.27% | 12/07/2023 | |
BNBX | Applied DNA Sciences | -$97.50 | -$180.00 | -$1.80 | 99.00% | $4.30M | $2.56M | $2.92M | 13.95% | 08/10/2023 | |
BNBX | Applied DNA Sciences | -$172.50 | -$150.00 | -$150.00 | 0.00% | $6.15M | $4.12M | $4.41M | 6.99% | 05/11/2023 | |
BNBX | Applied DNA Sciences | -$472.50 | -$217.50 | -$225.00 | -3.45% | $4.17M | $4.17M | $5.26M | 26.21% | 02/09/2023 | |
BNBX | Applied DNA Sciences | -$450.00 | -$195.00 | $7.50 | 103.85% | $3.00M | $4.10M | $3.56M | -13.20% | 12/14/2022 | |
BNBX | Applied DNA Sciences | -$345.00 | -$202.50 | -$97.50 | 51.85% | $1.70M | — | $4.30M | — | 08/11/2022 | |
BNBX | Applied DNA Sciences | -$247.50 | -$247.50 | -$172.50 | 30.30% | $2.67M | $4.50M | $6.15M | 36.60% | 05/12/2022 | |
BNBX | Applied DNA Sciences | -$420.00 | -$202.50 | -$472.50 | -133.33% | $1.62M | $4.02M | $4.17M | 3.63% | 02/10/2022 | |
BNBX | Applied DNA Sciences | -$615.00 | -$277.50 | -$450.00 | -62.16% | $314.00K | $2.30M | $3.00M | 30.43% | 12/09/2021 | |
BNBX | Applied DNA Sciences | -$540.00 | -$165.00 | -$345.00 | -109.09% | $431.52K | $3.13M | $1.70M | -45.69% | 08/12/2021 | |
BNBX | Applied DNA Sciences | -$592.50 | -$157.50 | -$247.50 | -57.14% | $552.47K | $2.60M | $2.67M | 2.77% | 05/13/2021 | |
BNBX | Applied DNA Sciences | -$840.00 | -$405.00 | -$420.00 | -3.70% | $633.52K | $1.36M | $1.62M | 18.82% | 02/11/2021 | |
BNBX | Applied DNA Sciences | -$1.08K | -$390.00 | -$615.00 | -57.69% | $1.70M | $710.00K | $314.00K | -55.77% | 12/17/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-08-14 | $-33.41 | $-37.50 | 10.9 % |
| Q2 | 2025-05-15 | $-230.25 | $-45.00 | -411.7 % |
| Q1 | 2025-02-13 | $-420.00 | $-247.50 | -69.7 % |
| Q4 | 2024-12-17 | $-240.00 | $-262.50 | 8.57 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-08-14 | $304.39K | $1.28M | -76.1 % |
| Q1 | 2025-02-13 | $1.20M | $1.18M | 1.44 % |
| Q4 | 2024-12-17 | $813.11K | $899.00K | -9.55 % |
| Q2 | 2024-05-10 | $929.63K | $950.00K | -2.14 % |
Está previsto que Applied DNA Sciences (BNBX) presente resultados el diciembre 16, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q3.
El BPA real fue de $-33.41, que superó la estimación de $-37.50.
Los ingresos reales fueron $304.4K, que no alcanzó la estimación de $1.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.